Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 6,116 Castle Biosciences, Inc. shares (Form 4)

Traded Nov 9 to Nov 11, 2026 · Filed Nov 12, 2026

From Nov 9 to Nov 11, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 6,116 Castle Biosciences, Inc. shares at an average US$33.77 for US$207K under a trading plan, leaving 32,737 shares. Filed Nov 12, 2026 (Form 4).

Sold
6,116 shares
Price
US$33.77 average (US$32.67 to US$35.04)
Value
US$207K
Holding after
32,737 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockSale3,288US$32.6735,565Direct
Nov 11, 2026Common StockSale2,828US$35.0432,737Direct

Source

Download original · View original at SEC

Related